Showing 1 - 2 results of 2 for search '"Karnofsky Performance Status"', query time: 0.14s Refine Results
  1. 1
    Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy

    Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy by Shigeo Ohba, Takao Teranishi, Kazuyasu Matsumura, Masanobu Kumon, Daijiro Kojima, Eiji Fujiwara, Kazutaka Nakao, Kiyonori Kuwahara, Kazuhiro Murayama, Eriel Sandika Pareira, Seiji Yamada, Masahiro Joko, Shunsuke Nakae, Jun Muto, Yuya Nishiyama, Kazuhide Adachi, Hikaru Sasaki, Masato Abe, Mitsuhiro Hasegawa, Yuichi Hirose

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Determining timeframes to death for imminently dying patients: a retrospective cohort study

    Determining timeframes to death for imminently dying patients: a retrospective cohort study by Tricia O’Connor, Wai-Man Liu, Juliane Samara, Joanne Lewis, Karen Strickland, Catherine Paterson

    Published 2025-01-01
    Subjects: “…Australia-modified Karnofsky Performance Status…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: